OA
CO

Operose Advisors’s Global Cord Blood Corporation CO Stock Holding History

Operose Advisors’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-200
Closed -$270 – 619
2024
Q1 		$270 Hold
200
– – ﹤0.01% 644
2023
Q4 		$244 Hold
200
– – ﹤0.01% 591
2023
Q3 		$248 Hold
200
– – ﹤0.01% 748
2023
Q2 		$210 Hold
200
– – ﹤0.01% 352
2023
Q1 		$596 Hold
200
– – ﹤0.01% 332
2022
Q4 		$596 Hold
200
– – ﹤0.01% 345
2022
Q3 		$1K Hold
200
– – ﹤0.01% 341
2022
Q2 		$1K Hold
200
– – ﹤0.01% 300
2022
Q1 		$1K Hold
200
– – ﹤0.01% 317
2021
Q4 		$1K Buy
+200
New +$849 ﹤0.01% 297

Other funds holding CO

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Operose Advisors's CO Position: Q2 2024 in Review

Operose Advisors sold out of Global Cord Blood Corporation (CO) in Q2 2024, closing a stake of 200 shares — an estimated $270 sold.

Operose Advisors first reported a position in CO in Q4 2021 and held it in 10 quarters. The position peaked at $1K in Q3 2022. 1 fund tracked by Wall St. Rank holds CO as of Q2 2024.

  • Operose Advisors reported no remaining Global Cord Blood Corporation position as of Q2 2024 after selling out during the quarter.
  • Operose Advisors sold 200 Global Cord Blood Corporation shares in Q2 2024, an estimated $270.
  • Operose Advisors first reported a position in Global Cord Blood Corporation in Q4 2021 and held it in 10 quarters.
  • Operose Advisors's Global Cord Blood Corporation position peaked at $1K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2024.

Based on Operose Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.